Angelo Scanio

Angelo Scanio

Auto-generated profile, based on publicly available information

Angelo Scanio

Department of Radiology, University of Texas Southwestern Medical Center , Dallas, TX 75390

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Radiology
Verified
Journal Article
Closed access
FKFernando U. Kay
Fernando U. Kay
ACArzu Canan
Arzu Canan
VKVishal Kukkar
Vishal Kukkar
KHKeith Hulsey
Keith Hulsey
ASAngelo Scanio
Angelo Scanio
RPRonald M. Peshock
Ronald M. Peshock
On-premises artificial intelligence was accurate in ruling out obstructive coronary artery disease at coronary CT angiography and achieved substantial to near-perfect agreement with human experts based on Coronary Artery Disease Reporting and Data System 2.0 categories for stenosis severity and plaque burden.

3 March 2026 in Radiology Advances
Verified
Journal Article
Open access
PDF file
CFChristopher M Fan
Christopher M Fan
ASAngelo Scanio
Angelo Scanio
PYPatricia Yokoo
Patricia Yokoo
MWMaya Wiessman
Maya Wiessman
MLMichael Long
Michael Long
FKFernando U. Kay
Fernando U. Kay
Background: Cardiomegaly is a clinically significant incidental finding on chest computed tomography (CT) associated with heart failure, arrhythmias, and sudden cardiac death. Qualitative radiologist assessment is variable, and automated AI tools may enable objective opportunistic cardiac volumetry. Purpose: To evaluate whether AI-enabled total cardiac volume (TCVAI) derived from non-ECG-gated, non-contrast chest CT can identify cardiomegaly as defined by echocardiography. Materials and Methods: This retrospective study included 307 consecutive patients (median age, 67 years; 56% male) who underwent non-contrast chest CT at a single center on 7 scanner types (4 vendors) and clinically indicated echocardiography within 31 days. A commercially available AI tool (AI-Rad Companion, Siemens Healthineers) automatically quantified TCVAI, indexed to body surface area (TCVAI/BSA). Echocardiography reports were reviewed for chamber dilation and left ventricular hypertrophy (LVH), collectively defined as cardiomegaly. Associations between TCVAI/BSA and echocardiographic findings were assessed using correlation, ordinal regression, and receiver operating characteristic (ROC). Interscan repeatability was evaluated in 248 patients with 544 repeat CT examinations. Prespecified sex-specific thresholds were tested in a temporally independent validation cohort of 50 patients. Results: Median TCVAI was higher in patients with cardiomegaly than those without (1061.9 vs 798.4 mL; P < .001). TCVAI/BSA was associated with chamber dilation and LVH severity on univariate analysis and remained associated in multivariable ordinal models, except for right ventricular dilation. Discriminatory performance was fair to good, with area under the curve (AUC) 0.81 (95% CI, 0.75-0.87) in men and 0.77 (95% CI, 0.69-0.85) in women. Interscan repeatability was excellent (intraclass correlation coefficient [ICC]: 0.93). In independent validation, performance ranged from sensitivity 89.3%/specificity 27.3% at a high-sensitivity threshold to sensitivity 28.6%/specificity 100% at a high-specificity threshold. Conclusion: AI-derived cardiac volume from routine chest CT shows fair to good performance for identifying echocardiography-defined cardiomegaly with high measurement repeatability, supporting a potential role for automated cardiac volumetry as an objective, opportunistic biomarker.